PAP

Persistent Asset Partners Portfolio holdings

AUM $258M
1-Year Est. Return 159.18%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+159.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$258M
AUM Growth
+$49.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
426
New
Increased
Reduced
Closed

Top Buys

1
+$9.09M
2
+$8.24M
3
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1
+$9.07M
2
+$8.9M
3
+$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 46.48%
2 Healthcare 30.91%
3 Financials 9.41%
4 Consumer Discretionary 4.08%
5 Energy 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
376
Altimmune
ALT
$572M
– –
0
AMLX icon
377
Amylyx Pharmaceuticals
AMLX
$1.44B
– –
-31,147
AMZN icon
378
Amazon
AMZN
$2.78T
– –
-1,600
APLT
379
DELISTED
Applied Therapeutics
APLT
– –
0
ARDX icon
380
Ardelyx
ARDX
$1.37B
– –
-60,490
ARKK icon
381
ARK Innovation ETF
ARKK
$6.72B
– –
0
JBIO
382
Jade Biosciences
JBIO
$872M
– –
-12,469
AVXL icon
383
Anavex Life Sciences
AVXL
$259M
– –
0
AXON icon
384
Axon Enterprise
AXON
$39.2B
– –
-1,000
BAC icon
385
Bank of America
BAC
$372B
– –
-21,050
BDTX icon
386
Black Diamond Therapeutics
BDTX
$127M
– –
0
BHVN icon
387
Biohaven
BHVN
$1.56B
– –
0
BILI icon
388
Bilibili
BILI
$7.81B
– –
-30,000
BLTE
389
Belite Bio
BLTE
$5.33B
– –
-673
BSX icon
390
Boston Scientific
BSX
$71.8B
– –
-8,748
CAH icon
391
Cardinal Health
CAH
$45.7B
– –
-5,695
CAT icon
392
Caterpillar
CAT
$416B
– –
0
CCL icon
393
Carnival Corporation Ltd
CCL
$37.9B
– –
0
CDTX
394
DELISTED
Cidara Therapeutics
CDTX
– –
-4,704
CDXS icon
395
Codexis
CDXS
$246M
– –
-27,813
CFG icon
396
Citizens Financial Group
CFG
$26.2B
– –
-11,696
CHE icon
397
Chemed
CHE
$5.57B
– –
-337
CNC icon
398
Centene
CNC
$29.9B
– –
-220,530
CNTA
399
Centessa Pharmaceuticals
CNTA
$6.17B
– –
-43,266
CRMD icon
400
CorMedix
CRMD
$643M
– –
0
13 14 15
16
17